nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—CYP3A4—breast cancer	0.192	1	CbGaD
Pyrazinamide—AOX1—Raloxifene—breast cancer	0.166	0.275	CbGbCtD
Pyrazinamide—XDH—Carboplatin—breast cancer	0.0693	0.115	CbGbCtD
Pyrazinamide—AOX1—Methotrexate—breast cancer	0.0445	0.0738	CbGbCtD
Pyrazinamide—XDH—Doxorubicin—breast cancer	0.0397	0.0658	CbGbCtD
Pyrazinamide—CYP1A2—Anastrozole—breast cancer	0.0369	0.0612	CbGbCtD
Pyrazinamide—CYP1A2—Toremifene—breast cancer	0.0337	0.056	CbGbCtD
Pyrazinamide—CYP3A4—Exemestane—breast cancer	0.0255	0.0423	CbGbCtD
Pyrazinamide—CYP3A4—Letrozole—breast cancer	0.0217	0.036	CbGbCtD
Pyrazinamide—CYP3A4—Anastrozole—breast cancer	0.0193	0.0321	CbGbCtD
Pyrazinamide—CYP3A4—Toremifene—breast cancer	0.0177	0.0293	CbGbCtD
Pyrazinamide—CYP3A4—Fulvestrant—breast cancer	0.0164	0.0273	CbGbCtD
Pyrazinamide—CYP3A4—Thiotepa—breast cancer	0.0146	0.0243	CbGbCtD
Pyrazinamide—CYP3A4—Ixabepilone—breast cancer	0.0134	0.0222	CbGbCtD
Pyrazinamide—CYP3A4—Lapatinib—breast cancer	0.0129	0.0214	CbGbCtD
Pyrazinamide—CYP1A2—Tamoxifen—breast cancer	0.0123	0.0204	CbGbCtD
Pyrazinamide—CYP3A4—Raloxifene—breast cancer	0.00977	0.0162	CbGbCtD
Pyrazinamide—CYP1A2—Fluorouracil—breast cancer	0.00908	0.0151	CbGbCtD
Pyrazinamide—CYP3A4—Vinorelbine—breast cancer	0.00715	0.0119	CbGbCtD
Pyrazinamide—CYP3A4—Tamoxifen—breast cancer	0.00646	0.0107	CbGbCtD
Pyrazinamide—CYP3A4—Mitoxantrone—breast cancer	0.0063	0.0104	CbGbCtD
Pyrazinamide—CYP3A4—Paclitaxel—breast cancer	0.00503	0.00833	CbGbCtD
Pyrazinamide—CYP3A4—Irinotecan—breast cancer	0.00496	0.00822	CbGbCtD
Pyrazinamide—CYP3A4—Vinblastine—breast cancer	0.00441	0.00731	CbGbCtD
Pyrazinamide—CYP3A4—Docetaxel—breast cancer	0.00363	0.00603	CbGbCtD
Pyrazinamide—CYP3A4—Doxorubicin—breast cancer	0.00271	0.00449	CbGbCtD
Pyrazinamide—AOX1—nipple—breast cancer	0.000481	0.112	CbGeAlD
Pyrazinamide—XDH—endometrium—breast cancer	0.000457	0.106	CbGeAlD
Pyrazinamide—XDH—female reproductive system—breast cancer	0.000379	0.0878	CbGeAlD
Pyrazinamide—XDH—endocrine gland—breast cancer	0.000321	0.0743	CbGeAlD
Pyrazinamide—AOX1—endometrium—breast cancer	0.000291	0.0674	CbGeAlD
Pyrazinamide—AOX1—uterus—breast cancer	0.000268	0.0621	CbGeAlD
Pyrazinamide—CYP1A2—nipple—breast cancer	0.000264	0.0612	CbGeAlD
Pyrazinamide—AOX1—pituitary gland—breast cancer	0.000263	0.061	CbGeAlD
Pyrazinamide—AOX1—adipose tissue—breast cancer	0.000262	0.0607	CbGeAlD
Pyrazinamide—AOX1—female reproductive system—breast cancer	0.000241	0.0558	CbGeAlD
Pyrazinamide—AOX1—adrenal gland—breast cancer	0.000235	0.0545	CbGeAlD
Pyrazinamide—AOX1—female gonad—breast cancer	0.000219	0.0508	CbGeAlD
Pyrazinamide—AOX1—endocrine gland—breast cancer	0.000204	0.0472	CbGeAlD
Pyrazinamide—Feeling abnormal—Goserelin—breast cancer	0.000187	0.00147	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Gemcitabine—breast cancer	0.000185	0.00146	CcSEcCtD
Pyrazinamide—Malaise—Irinotecan—breast cancer	0.000185	0.00146	CcSEcCtD
Pyrazinamide—Malaise—Mitoxantrone—breast cancer	0.000185	0.00146	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Vinorelbine—breast cancer	0.000185	0.00146	CcSEcCtD
Pyrazinamide—Anorexia—Thiotepa—breast cancer	0.000185	0.00146	CcSEcCtD
Pyrazinamide—Urticaria—Melphalan—breast cancer	0.000185	0.00146	CcSEcCtD
Pyrazinamide—Dysuria—Capecitabine—breast cancer	0.000184	0.00145	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Doxorubicin—breast cancer	0.000184	0.00145	CcSEcCtD
Pyrazinamide—Photosensitivity—Epirubicin—breast cancer	0.000181	0.00143	CcSEcCtD
Pyrazinamide—Malaise—Gemcitabine—breast cancer	0.00018	0.00142	CcSEcCtD
Pyrazinamide—Urticaria—Goserelin—breast cancer	0.00018	0.00142	CcSEcCtD
Pyrazinamide—Hypersensitivity—Vinblastine—breast cancer	0.00018	0.00142	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Capecitabine—breast cancer	0.00018	0.00142	CcSEcCtD
Pyrazinamide—Body temperature increased—Goserelin—breast cancer	0.000179	0.00141	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000177	0.00139	CcSEcCtD
Pyrazinamide—Decreased appetite—Vinorelbine—breast cancer	0.000176	0.00139	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000175	0.00138	CcSEcCtD
Pyrazinamide—Hypersensitivity—Tamoxifen—breast cancer	0.000175	0.00138	CcSEcCtD
Pyrazinamide—Arthralgia—Mitoxantrone—breast cancer	0.000175	0.00138	CcSEcCtD
Pyrazinamide—Myalgia—Mitoxantrone—breast cancer	0.000175	0.00138	CcSEcCtD
Pyrazinamide—Discomfort—Irinotecan—breast cancer	0.000173	0.00136	CcSEcCtD
Pyrazinamide—Discomfort—Mitoxantrone—breast cancer	0.000173	0.00136	CcSEcCtD
Pyrazinamide—Hypersensitivity—Melphalan—breast cancer	0.000171	0.00135	CcSEcCtD
Pyrazinamide—Dyspepsia—Thiotepa—breast cancer	0.000171	0.00135	CcSEcCtD
Pyrazinamide—Arthralgia—Gemcitabine—breast cancer	0.00017	0.00134	CcSEcCtD
Pyrazinamide—Myalgia—Gemcitabine—breast cancer	0.00017	0.00134	CcSEcCtD
Pyrazinamide—Vomiting—Chlorambucil—breast cancer	0.000169	0.00134	CcSEcCtD
Pyrazinamide—Decreased appetite—Thiotepa—breast cancer	0.000168	0.00133	CcSEcCtD
Pyrazinamide—Discomfort—Gemcitabine—breast cancer	0.000168	0.00133	CcSEcCtD
Pyrazinamide—Pruritus—Tamoxifen—breast cancer	0.000168	0.00132	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Thiotepa—breast cancer	0.000167	0.00132	CcSEcCtD
Pyrazinamide—Photosensitivity—Doxorubicin—breast cancer	0.000167	0.00132	CcSEcCtD
Pyrazinamide—Feeling abnormal—Vinorelbine—breast cancer	0.000167	0.00132	CcSEcCtD
Pyrazinamide—Myalgia—Fluorouracil—breast cancer	0.000167	0.00132	CcSEcCtD
Pyrazinamide—Hypersensitivity—Goserelin—breast cancer	0.000167	0.00132	CcSEcCtD
Pyrazinamide—Discomfort—Fluorouracil—breast cancer	0.000165	0.0013	CcSEcCtD
Pyrazinamide—Pruritus—Melphalan—breast cancer	0.000164	0.0013	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Mitoxantrone—breast cancer	0.000164	0.00129	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Irinotecan—breast cancer	0.000164	0.00129	CcSEcCtD
Pyrazinamide—Hepatitis—Docetaxel—breast cancer	0.000163	0.00128	CcSEcCtD
Pyrazinamide—Urticaria—Vinorelbine—breast cancer	0.000161	0.00127	CcSEcCtD
Pyrazinamide—Body temperature increased—Vinorelbine—breast cancer	0.00016	0.00127	CcSEcCtD
Pyrazinamide—Pruritus—Goserelin—breast cancer	0.00016	0.00126	CcSEcCtD
Pyrazinamide—Feeling abnormal—Thiotepa—breast cancer	0.00016	0.00126	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Gemcitabine—breast cancer	0.00016	0.00126	CcSEcCtD
Pyrazinamide—Anorexia—Mitoxantrone—breast cancer	0.00016	0.00126	CcSEcCtD
Pyrazinamide—Anorexia—Irinotecan—breast cancer	0.00016	0.00126	CcSEcCtD
Pyrazinamide—Nausea—Chlorambucil—breast cancer	0.000158	0.00125	CcSEcCtD
Pyrazinamide—Hepatitis—Capecitabine—breast cancer	0.000158	0.00124	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Fluorouracil—breast cancer	0.000157	0.00124	CcSEcCtD
Pyrazinamide—Anorexia—Gemcitabine—breast cancer	0.000155	0.00123	CcSEcCtD
Pyrazinamide—Vomiting—Vinblastine—breast cancer	0.000155	0.00122	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Paclitaxel—breast cancer	0.000155	0.00122	CcSEcCtD
Pyrazinamide—Urticaria—Thiotepa—breast cancer	0.000154	0.00121	CcSEcCtD
Pyrazinamide—Body temperature increased—Thiotepa—breast cancer	0.000153	0.00121	CcSEcCtD
Pyrazinamide—Anorexia—Fluorouracil—breast cancer	0.000153	0.00121	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000153	0.0012	CcSEcCtD
Pyrazinamide—Vomiting—Tamoxifen—breast cancer	0.000151	0.00119	CcSEcCtD
Pyrazinamide—Malaise—Paclitaxel—breast cancer	0.000151	0.00119	CcSEcCtD
Pyrazinamide—Rash—Tamoxifen—breast cancer	0.00015	0.00118	CcSEcCtD
Pyrazinamide—Hypersensitivity—Vinorelbine—breast cancer	0.00015	0.00118	CcSEcCtD
Pyrazinamide—Dermatitis—Tamoxifen—breast cancer	0.000149	0.00118	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000149	0.00117	CcSEcCtD
Pyrazinamide—Vomiting—Melphalan—breast cancer	0.000148	0.00116	CcSEcCtD
Pyrazinamide—Dyspepsia—Mitoxantrone—breast cancer	0.000147	0.00116	CcSEcCtD
Pyrazinamide—Dyspepsia—Irinotecan—breast cancer	0.000147	0.00116	CcSEcCtD
Pyrazinamide—Rash—Melphalan—breast cancer	0.000146	0.00116	CcSEcCtD
Pyrazinamide—Dermatitis—Melphalan—breast cancer	0.000146	0.00115	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000146	0.00115	CcSEcCtD
Pyrazinamide—Decreased appetite—Irinotecan—breast cancer	0.000146	0.00115	CcSEcCtD
Pyrazinamide—Decreased appetite—Mitoxantrone—breast cancer	0.000146	0.00115	CcSEcCtD
Pyrazinamide—Nausea—Vinblastine—breast cancer	0.000145	0.00114	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Irinotecan—breast cancer	0.000145	0.00114	CcSEcCtD
Pyrazinamide—Vomiting—Goserelin—breast cancer	0.000144	0.00114	CcSEcCtD
Pyrazinamide—Pruritus—Vinorelbine—breast cancer	0.000144	0.00113	CcSEcCtD
Pyrazinamide—Rash—Goserelin—breast cancer	0.000143	0.00113	CcSEcCtD
Pyrazinamide—Hypersensitivity—Thiotepa—breast cancer	0.000143	0.00113	CcSEcCtD
Pyrazinamide—Dermatitis—Goserelin—breast cancer	0.000143	0.00113	CcSEcCtD
Pyrazinamide—Arthralgia—Paclitaxel—breast cancer	0.000142	0.00112	CcSEcCtD
Pyrazinamide—Myalgia—Paclitaxel—breast cancer	0.000142	0.00112	CcSEcCtD
Pyrazinamide—Decreased appetite—Gemcitabine—breast cancer	0.000142	0.00112	CcSEcCtD
Pyrazinamide—Dyspepsia—Fluorouracil—breast cancer	0.000141	0.00111	CcSEcCtD
Pyrazinamide—Nausea—Tamoxifen—breast cancer	0.000141	0.00111	CcSEcCtD
Pyrazinamide—AOX1—lymph node—breast cancer	0.000141	0.0327	CbGeAlD
Pyrazinamide—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000141	0.00111	CcSEcCtD
Pyrazinamide—Discomfort—Paclitaxel—breast cancer	0.000141	0.00111	CcSEcCtD
Pyrazinamide—Decreased appetite—Fluorouracil—breast cancer	0.000139	0.0011	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000138	0.00109	CcSEcCtD
Pyrazinamide—Nausea—Melphalan—breast cancer	0.000138	0.00109	CcSEcCtD
Pyrazinamide—Feeling abnormal—Irinotecan—breast cancer	0.000138	0.00109	CcSEcCtD
Pyrazinamide—Feeling abnormal—Mitoxantrone—breast cancer	0.000138	0.00109	CcSEcCtD
Pyrazinamide—Dysuria—Methotrexate—breast cancer	0.000137	0.00108	CcSEcCtD
Pyrazinamide—Pruritus—Thiotepa—breast cancer	0.000137	0.00108	CcSEcCtD
Pyrazinamide—Nausea—Goserelin—breast cancer	0.000135	0.00106	CcSEcCtD
Pyrazinamide—Feeling abnormal—Gemcitabine—breast cancer	0.000134	0.00106	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Methotrexate—breast cancer	0.000134	0.00106	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Paclitaxel—breast cancer	0.000134	0.00105	CcSEcCtD
Pyrazinamide—Urticaria—Mitoxantrone—breast cancer	0.000133	0.00105	CcSEcCtD
Pyrazinamide—Body temperature increased—Irinotecan—breast cancer	0.000132	0.00104	CcSEcCtD
Pyrazinamide—Body temperature increased—Mitoxantrone—breast cancer	0.000132	0.00104	CcSEcCtD
Pyrazinamide—Feeling abnormal—Fluorouracil—breast cancer	0.000132	0.00104	CcSEcCtD
Pyrazinamide—Anorexia—Paclitaxel—breast cancer	0.00013	0.00103	CcSEcCtD
Pyrazinamide—Vomiting—Vinorelbine—breast cancer	0.000129	0.00102	CcSEcCtD
Pyrazinamide—Body temperature increased—Gemcitabine—breast cancer	0.000129	0.00102	CcSEcCtD
Pyrazinamide—Dysuria—Epirubicin—breast cancer	0.000128	0.00101	CcSEcCtD
Pyrazinamide—Rash—Vinorelbine—breast cancer	0.000128	0.00101	CcSEcCtD
Pyrazinamide—Dermatitis—Vinorelbine—breast cancer	0.000128	0.00101	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Capecitabine—breast cancer	0.000127	0.001	CcSEcCtD
Pyrazinamide—Urticaria—Fluorouracil—breast cancer	0.000127	0.001	CcSEcCtD
Pyrazinamide—Body temperature increased—Fluorouracil—breast cancer	0.000127	0.000999	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Epirubicin—breast cancer	0.000125	0.000988	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000124	0.000981	CcSEcCtD
Pyrazinamide—Malaise—Capecitabine—breast cancer	0.000124	0.000976	CcSEcCtD
Pyrazinamide—Hypersensitivity—Mitoxantrone—breast cancer	0.000123	0.000973	CcSEcCtD
Pyrazinamide—Hypersensitivity—Irinotecan—breast cancer	0.000123	0.000973	CcSEcCtD
Pyrazinamide—Vomiting—Thiotepa—breast cancer	0.000123	0.000972	CcSEcCtD
Pyrazinamide—Rash—Thiotepa—breast cancer	0.000122	0.000964	CcSEcCtD
Pyrazinamide—Dermatitis—Thiotepa—breast cancer	0.000122	0.000963	CcSEcCtD
Pyrazinamide—Arthralgia—Docetaxel—breast cancer	0.000121	0.000952	CcSEcCtD
Pyrazinamide—Myalgia—Docetaxel—breast cancer	0.000121	0.000952	CcSEcCtD
Pyrazinamide—Nausea—Vinorelbine—breast cancer	0.000121	0.000951	CcSEcCtD
Pyrazinamide—Dyspepsia—Paclitaxel—breast cancer	0.00012	0.000948	CcSEcCtD
Pyrazinamide—Dysuria—Doxorubicin—breast cancer	0.000119	0.000936	CcSEcCtD
Pyrazinamide—Decreased appetite—Paclitaxel—breast cancer	0.000119	0.000936	CcSEcCtD
Pyrazinamide—Hypersensitivity—Fluorouracil—breast cancer	0.000118	0.000931	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000118	0.000929	CcSEcCtD
Pyrazinamide—Hepatitis—Methotrexate—breast cancer	0.000117	0.000926	CcSEcCtD
Pyrazinamide—Myalgia—Capecitabine—breast cancer	0.000117	0.000922	CcSEcCtD
Pyrazinamide—Arthralgia—Capecitabine—breast cancer	0.000117	0.000922	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Doxorubicin—breast cancer	0.000116	0.000914	CcSEcCtD
Pyrazinamide—Discomfort—Capecitabine—breast cancer	0.000115	0.000911	CcSEcCtD
Pyrazinamide—Pruritus—Gemcitabine—breast cancer	0.000115	0.00091	CcSEcCtD
Pyrazinamide—Nausea—Thiotepa—breast cancer	0.000115	0.000908	CcSEcCtD
Pyrazinamide—Pruritus—Fluorouracil—breast cancer	0.000113	0.000894	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Docetaxel—breast cancer	0.000113	0.000893	CcSEcCtD
Pyrazinamide—Feeling abnormal—Paclitaxel—breast cancer	0.000112	0.000887	CcSEcCtD
Pyrazinamide—CYP1A2—endocrine gland—breast cancer	0.000112	0.0259	CbGeAlD
Pyrazinamide—Anorexia—Docetaxel—breast cancer	0.00011	0.00087	CcSEcCtD
Pyrazinamide—Hepatitis—Epirubicin—breast cancer	0.00011	0.000866	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Capecitabine—breast cancer	0.00011	0.000865	CcSEcCtD
Pyrazinamide—Urticaria—Paclitaxel—breast cancer	0.000108	0.000855	CcSEcCtD
Pyrazinamide—Body temperature increased—Paclitaxel—breast cancer	0.000108	0.000851	CcSEcCtD
Pyrazinamide—Anorexia—Capecitabine—breast cancer	0.000107	0.000842	CcSEcCtD
Pyrazinamide—Vomiting—Irinotecan—breast cancer	0.000106	0.000839	CcSEcCtD
Pyrazinamide—Vomiting—Mitoxantrone—breast cancer	0.000106	0.000839	CcSEcCtD
Pyrazinamide—Rash—Irinotecan—breast cancer	0.000106	0.000832	CcSEcCtD
Pyrazinamide—Rash—Mitoxantrone—breast cancer	0.000106	0.000832	CcSEcCtD
Pyrazinamide—Dermatitis—Irinotecan—breast cancer	0.000105	0.000832	CcSEcCtD
Pyrazinamide—Dermatitis—Mitoxantrone—breast cancer	0.000105	0.000832	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000105	0.000831	CcSEcCtD
Pyrazinamide—Vomiting—Gemcitabine—breast cancer	0.000104	0.000818	CcSEcCtD
Pyrazinamide—Rash—Gemcitabine—breast cancer	0.000103	0.000811	CcSEcCtD
Pyrazinamide—Dermatitis—Gemcitabine—breast cancer	0.000103	0.00081	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000102	0.000805	CcSEcCtD
Pyrazinamide—Vomiting—Fluorouracil—breast cancer	0.000102	0.000804	CcSEcCtD
Pyrazinamide—Dyspepsia—Docetaxel—breast cancer	0.000102	0.000803	CcSEcCtD
Pyrazinamide—Hepatitis—Doxorubicin—breast cancer	0.000102	0.000802	CcSEcCtD
Pyrazinamide—Rash—Fluorouracil—breast cancer	0.000101	0.000797	CcSEcCtD
Pyrazinamide—Dermatitis—Fluorouracil—breast cancer	0.000101	0.000796	CcSEcCtD
Pyrazinamide—Decreased appetite—Docetaxel—breast cancer	0.000101	0.000793	CcSEcCtD
Pyrazinamide—Hypersensitivity—Paclitaxel—breast cancer	0.000101	0.000793	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Docetaxel—breast cancer	9.99e-05	0.000788	CcSEcCtD
Pyrazinamide—Nausea—Irinotecan—breast cancer	9.94e-05	0.000784	CcSEcCtD
Pyrazinamide—Nausea—Mitoxantrone—breast cancer	9.94e-05	0.000784	CcSEcCtD
Pyrazinamide—Dyspepsia—Capecitabine—breast cancer	9.86e-05	0.000778	CcSEcCtD
Pyrazinamide—Decreased appetite—Capecitabine—breast cancer	9.74e-05	0.000768	CcSEcCtD
Pyrazinamide—Nausea—Gemcitabine—breast cancer	9.69e-05	0.000764	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Capecitabine—breast cancer	9.67e-05	0.000763	CcSEcCtD
Pyrazinamide—Pruritus—Paclitaxel—breast cancer	9.66e-05	0.000762	CcSEcCtD
Pyrazinamide—CYP3A4—female reproductive system—breast cancer	9.56e-05	0.0222	CbGeAlD
Pyrazinamide—Feeling abnormal—Docetaxel—breast cancer	9.54e-05	0.000752	CcSEcCtD
Pyrazinamide—Nausea—Fluorouracil—breast cancer	9.52e-05	0.000751	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methotrexate—breast cancer	9.48e-05	0.000748	CcSEcCtD
Pyrazinamide—Feeling abnormal—Capecitabine—breast cancer	9.23e-05	0.000728	CcSEcCtD
Pyrazinamide—Malaise—Methotrexate—breast cancer	9.22e-05	0.000727	CcSEcCtD
Pyrazinamide—Body temperature increased—Docetaxel—breast cancer	9.15e-05	0.000721	CcSEcCtD
Pyrazinamide—Urticaria—Capecitabine—breast cancer	8.9e-05	0.000702	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Epirubicin—breast cancer	8.87e-05	0.0007	CcSEcCtD
Pyrazinamide—Body temperature increased—Capecitabine—breast cancer	8.86e-05	0.000698	CcSEcCtD
Pyrazinamide—Arthralgia—Methotrexate—breast cancer	8.7e-05	0.000686	CcSEcCtD
Pyrazinamide—Myalgia—Methotrexate—breast cancer	8.7e-05	0.000686	CcSEcCtD
Pyrazinamide—Vomiting—Paclitaxel—breast cancer	8.68e-05	0.000684	CcSEcCtD
Pyrazinamide—Malaise—Epirubicin—breast cancer	8.62e-05	0.00068	CcSEcCtD
Pyrazinamide—Rash—Paclitaxel—breast cancer	8.61e-05	0.000679	CcSEcCtD
Pyrazinamide—Dermatitis—Paclitaxel—breast cancer	8.6e-05	0.000678	CcSEcCtD
Pyrazinamide—Discomfort—Methotrexate—breast cancer	8.6e-05	0.000678	CcSEcCtD
Pyrazinamide—Hypersensitivity—Docetaxel—breast cancer	8.53e-05	0.000672	CcSEcCtD
Pyrazinamide—Hypersensitivity—Capecitabine—breast cancer	8.25e-05	0.000651	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Doxorubicin—breast cancer	8.21e-05	0.000647	CcSEcCtD
Pyrazinamide—Pruritus—Docetaxel—breast cancer	8.19e-05	0.000646	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Methotrexate—breast cancer	8.17e-05	0.000644	CcSEcCtD
Pyrazinamide—Arthralgia—Epirubicin—breast cancer	8.14e-05	0.000642	CcSEcCtD
Pyrazinamide—Myalgia—Epirubicin—breast cancer	8.14e-05	0.000642	CcSEcCtD
Pyrazinamide—Nausea—Paclitaxel—breast cancer	8.11e-05	0.000639	CcSEcCtD
Pyrazinamide—CYP3A4—endocrine gland—breast cancer	8.09e-05	0.0188	CbGeAlD
Pyrazinamide—Discomfort—Epirubicin—breast cancer	8.04e-05	0.000634	CcSEcCtD
Pyrazinamide—Malaise—Doxorubicin—breast cancer	7.98e-05	0.000629	CcSEcCtD
Pyrazinamide—Anorexia—Methotrexate—breast cancer	7.95e-05	0.000627	CcSEcCtD
Pyrazinamide—Pruritus—Capecitabine—breast cancer	7.93e-05	0.000625	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Epirubicin—breast cancer	7.64e-05	0.000603	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Methotrexate—breast cancer	7.6e-05	0.000599	CcSEcCtD
Pyrazinamide—Arthralgia—Doxorubicin—breast cancer	7.53e-05	0.000594	CcSEcCtD
Pyrazinamide—Myalgia—Doxorubicin—breast cancer	7.53e-05	0.000594	CcSEcCtD
Pyrazinamide—Discomfort—Doxorubicin—breast cancer	7.44e-05	0.000587	CcSEcCtD
Pyrazinamide—Anorexia—Epirubicin—breast cancer	7.44e-05	0.000587	CcSEcCtD
Pyrazinamide—Vomiting—Docetaxel—breast cancer	7.36e-05	0.00058	CcSEcCtD
Pyrazinamide—Dyspepsia—Methotrexate—breast cancer	7.34e-05	0.000579	CcSEcCtD
Pyrazinamide—Rash—Docetaxel—breast cancer	7.3e-05	0.000575	CcSEcCtD
Pyrazinamide—Dermatitis—Docetaxel—breast cancer	7.29e-05	0.000575	CcSEcCtD
Pyrazinamide—Decreased appetite—Methotrexate—breast cancer	7.25e-05	0.000572	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Methotrexate—breast cancer	7.2e-05	0.000568	CcSEcCtD
Pyrazinamide—Vomiting—Capecitabine—breast cancer	7.12e-05	0.000562	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Epirubicin—breast cancer	7.11e-05	0.000561	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Doxorubicin—breast cancer	7.07e-05	0.000558	CcSEcCtD
Pyrazinamide—Rash—Capecitabine—breast cancer	7.06e-05	0.000557	CcSEcCtD
Pyrazinamide—Dermatitis—Capecitabine—breast cancer	7.06e-05	0.000557	CcSEcCtD
Pyrazinamide—Anorexia—Doxorubicin—breast cancer	6.88e-05	0.000543	CcSEcCtD
Pyrazinamide—Nausea—Docetaxel—breast cancer	6.87e-05	0.000542	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methotrexate—breast cancer	6.87e-05	0.000542	CcSEcCtD
Pyrazinamide—Dyspepsia—Epirubicin—breast cancer	6.87e-05	0.000542	CcSEcCtD
Pyrazinamide—Decreased appetite—Epirubicin—breast cancer	6.78e-05	0.000535	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Epirubicin—breast cancer	6.74e-05	0.000531	CcSEcCtD
Pyrazinamide—Nausea—Capecitabine—breast cancer	6.65e-05	0.000525	CcSEcCtD
Pyrazinamide—Urticaria—Methotrexate—breast cancer	6.63e-05	0.000522	CcSEcCtD
Pyrazinamide—Body temperature increased—Methotrexate—breast cancer	6.59e-05	0.00052	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.58e-05	0.000519	CcSEcCtD
Pyrazinamide—Feeling abnormal—Epirubicin—breast cancer	6.43e-05	0.000507	CcSEcCtD
Pyrazinamide—Dyspepsia—Doxorubicin—breast cancer	6.36e-05	0.000501	CcSEcCtD
Pyrazinamide—Decreased appetite—Doxorubicin—breast cancer	6.28e-05	0.000495	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Doxorubicin—breast cancer	6.23e-05	0.000492	CcSEcCtD
Pyrazinamide—Urticaria—Epirubicin—breast cancer	6.2e-05	0.000489	CcSEcCtD
Pyrazinamide—Body temperature increased—Epirubicin—breast cancer	6.17e-05	0.000487	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methotrexate—breast cancer	6.14e-05	0.000485	CcSEcCtD
Pyrazinamide—Feeling abnormal—Doxorubicin—breast cancer	5.95e-05	0.000469	CcSEcCtD
Pyrazinamide—Pruritus—Methotrexate—breast cancer	5.9e-05	0.000465	CcSEcCtD
Pyrazinamide—Hypersensitivity—Epirubicin—breast cancer	5.75e-05	0.000453	CcSEcCtD
Pyrazinamide—Urticaria—Doxorubicin—breast cancer	5.74e-05	0.000452	CcSEcCtD
Pyrazinamide—Body temperature increased—Doxorubicin—breast cancer	5.71e-05	0.00045	CcSEcCtD
Pyrazinamide—Pruritus—Epirubicin—breast cancer	5.52e-05	0.000435	CcSEcCtD
Pyrazinamide—Hypersensitivity—Doxorubicin—breast cancer	5.32e-05	0.00042	CcSEcCtD
Pyrazinamide—Vomiting—Methotrexate—breast cancer	5.3e-05	0.000418	CcSEcCtD
Pyrazinamide—Rash—Methotrexate—breast cancer	5.26e-05	0.000415	CcSEcCtD
Pyrazinamide—Dermatitis—Methotrexate—breast cancer	5.25e-05	0.000414	CcSEcCtD
Pyrazinamide—Pruritus—Doxorubicin—breast cancer	5.11e-05	0.000403	CcSEcCtD
Pyrazinamide—Vomiting—Epirubicin—breast cancer	4.96e-05	0.000391	CcSEcCtD
Pyrazinamide—Nausea—Methotrexate—breast cancer	4.95e-05	0.000391	CcSEcCtD
Pyrazinamide—Rash—Epirubicin—breast cancer	4.92e-05	0.000388	CcSEcCtD
Pyrazinamide—Dermatitis—Epirubicin—breast cancer	4.92e-05	0.000388	CcSEcCtD
Pyrazinamide—Nausea—Epirubicin—breast cancer	4.64e-05	0.000366	CcSEcCtD
Pyrazinamide—Vomiting—Doxorubicin—breast cancer	4.59e-05	0.000362	CcSEcCtD
Pyrazinamide—Rash—Doxorubicin—breast cancer	4.55e-05	0.000359	CcSEcCtD
Pyrazinamide—Dermatitis—Doxorubicin—breast cancer	4.55e-05	0.000359	CcSEcCtD
Pyrazinamide—Nausea—Doxorubicin—breast cancer	4.29e-05	0.000338	CcSEcCtD
Pyrazinamide—XDH—Metabolism—ERCC2—breast cancer	1.88e-05	0.000253	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SYNJ2—breast cancer	1.88e-05	0.000253	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.88e-05	0.000252	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.8e-05	0.000242	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—BRAF—breast cancer	1.8e-05	0.000241	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.78e-05	0.000239	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MTHFR—breast cancer	1.77e-05	0.000238	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CAV1—breast cancer	1.76e-05	0.000236	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT2—breast cancer	1.75e-05	0.000235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NDUFS3—breast cancer	1.75e-05	0.000235	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	1.68e-05	0.000226	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CD—breast cancer	1.68e-05	0.000226	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SERPINE1—breast cancer	1.66e-05	0.000223	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CHST9—breast cancer	1.64e-05	0.000221	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CAV1—breast cancer	1.63e-05	0.000219	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	1.61e-05	0.000216	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CG—breast cancer	1.6e-05	0.000215	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS3—breast cancer	1.59e-05	0.000213	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	1.56e-05	0.00021	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—COX11—breast cancer	1.56e-05	0.000209	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	1.53e-05	0.000206	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MDM2—breast cancer	1.5e-05	0.000202	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RAF1—breast cancer	1.5e-05	0.000202	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CG—breast cancer	1.49e-05	0.0002	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	1.49e-05	0.0002	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERBB2—breast cancer	1.48e-05	0.000199	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTOR—breast cancer	1.46e-05	0.000197	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CB—breast cancer	1.46e-05	0.000197	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD4—breast cancer	1.46e-05	0.000196	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—breast cancer	1.45e-05	0.000195	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SYNJ2—breast cancer	1.45e-05	0.000195	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CDA—breast cancer	1.42e-05	0.000191	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SHMT1—breast cancer	1.42e-05	0.000191	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CD—breast cancer	1.41e-05	0.000189	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	1.41e-05	0.000189	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.39e-05	0.000187	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—breast cancer	1.39e-05	0.000187	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1B—breast cancer	1.37e-05	0.000185	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC2A5—breast cancer	1.37e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLCO1B1—breast cancer	1.37e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NDUFS3—breast cancer	1.35e-05	0.000181	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.34e-05	0.00018	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NOS3—breast cancer	1.33e-05	0.000178	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APRT—breast cancer	1.32e-05	0.000178	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CD—breast cancer	1.31e-05	0.000176	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.3e-05	0.000175	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CTNNB1—breast cancer	1.3e-05	0.000174	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.29e-05	0.000174	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—breast cancer	1.29e-05	0.000173	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1A—breast cancer	1.27e-05	0.00017	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CHST9—breast cancer	1.27e-05	0.00017	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTEN—breast cancer	1.27e-05	0.00017	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ESRRA—breast cancer	1.24e-05	0.000167	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ANGPTL4—breast cancer	1.24e-05	0.000167	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NOS3—breast cancer	1.23e-05	0.000166	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CB—breast cancer	1.23e-05	0.000165	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—breast cancer	1.21e-05	0.000163	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—COX11—breast cancer	1.2e-05	0.000161	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.18e-05	0.000159	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HADHB—breast cancer	1.18e-05	0.000159	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPI—breast cancer	1.18e-05	0.000159	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SRC—breast cancer	1.17e-05	0.000158	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CB—breast cancer	1.14e-05	0.000153	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—STAT3—breast cancer	1.13e-05	0.000152	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—breast cancer	1.13e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.13e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDH1A1—breast cancer	1.13e-05	0.000151	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDH7A1—breast cancer	1.13e-05	0.000151	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.11e-05	0.00015	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CDA—breast cancer	1.1e-05	0.000148	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SHMT1—breast cancer	1.1e-05	0.000148	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK3—breast cancer	1.08e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FHL2—breast cancer	1.08e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NME1—breast cancer	1.08e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ADSL—breast cancer	1.08e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PHGDH—breast cancer	1.08e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UMPS—breast cancer	1.08e-05	0.000145	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTEN—breast cancer	1.06e-05	0.000142	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HPSE—breast cancer	1.06e-05	0.000142	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—BRIP1—breast cancer	1.06e-05	0.000142	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LDHB—breast cancer	1.06e-05	0.000142	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC2A5—breast cancer	1.06e-05	0.000142	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.06e-05	0.000142	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MYC—breast cancer	1.05e-05	0.000141	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TGFB1—breast cancer	1.05e-05	0.000141	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EGFR—breast cancer	1.03e-05	0.000138	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APRT—breast cancer	1.02e-05	0.000137	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA3—breast cancer	1e-05	0.000135	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMMR—breast cancer	1e-05	0.000135	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCC1—breast cancer	1e-05	0.000135	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTEN—breast cancer	9.85e-06	0.000132	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARGC1B—breast cancer	9.72e-06	0.000131	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KRAS—breast cancer	9.71e-06	0.000131	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ESRRA—breast cancer	9.61e-06	0.000129	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.61e-06	0.000129	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	9.46e-06	0.000127	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	9.46e-06	0.000127	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CA9—breast cancer	9.18e-06	0.000123	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA4—breast cancer	9.18e-06	0.000123	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HADHB—breast cancer	9.11e-06	0.000122	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPI—breast cancer	9.11e-06	0.000122	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	9.06e-06	0.000122	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	8.97e-06	0.000121	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA2—breast cancer	8.94e-06	0.00012	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX2—breast cancer	8.94e-06	0.00012	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CA—breast cancer	8.92e-06	0.00012	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX4—breast cancer	8.83e-06	0.000119	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SULT1A1—breast cancer	8.83e-06	0.000119	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.69e-06	0.000117	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.69e-06	0.000117	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—IDH1—breast cancer	8.63e-06	0.000116	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA1—breast cancer	8.63e-06	0.000116	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NAT2—breast cancer	8.53e-06	0.000115	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FHL2—breast cancer	8.33e-06	0.000112	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NME1—breast cancer	8.33e-06	0.000112	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UMPS—breast cancer	8.33e-06	0.000112	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ADSL—breast cancer	8.33e-06	0.000112	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PHGDH—breast cancer	8.33e-06	0.000112	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HRAS—breast cancer	8.26e-06	0.000111	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LDHB—breast cancer	8.17e-06	0.00011	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—BRIP1—breast cancer	8.17e-06	0.00011	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HPSE—breast cancer	8.17e-06	0.00011	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—breast cancer	7.9e-06	0.000106	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMMR—breast cancer	7.74e-06	0.000104	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA3—breast cancer	7.74e-06	0.000104	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCC1—breast cancer	7.74e-06	0.000104	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.71e-06	0.000104	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.5e-06	0.000101	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MED12—breast cancer	7.48e-06	0.000101	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—DPYD—breast cancer	7.48e-06	0.000101	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CA—breast cancer	7.47e-06	0.0001	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDOA—breast cancer	7.36e-06	9.9e-05	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT1—breast cancer	7.29e-06	9.8e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOA3—breast cancer	7.15e-06	9.61e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC2A2—breast cancer	7.1e-06	9.54e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA4—breast cancer	7.08e-06	9.52e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CA9—breast cancer	7.08e-06	9.52e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.03e-06	9.44e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCG2—breast cancer	6.95e-06	9.35e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CPT1A—breast cancer	6.95e-06	9.35e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTR—breast cancer	6.95e-06	9.35e-05	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CA—breast cancer	6.95e-06	9.34e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA2—breast cancer	6.9e-06	9.28e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX2—breast cancer	6.9e-06	9.28e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HPGDS—breast cancer	6.82e-06	9.17e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX4—breast cancer	6.82e-06	9.16e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SULT1A1—breast cancer	6.82e-06	9.16e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HBA1—breast cancer	6.78e-06	9.11e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—IDH1—breast cancer	6.66e-06	8.95e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA1—breast cancer	6.66e-06	8.95e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTT1—breast cancer	6.62e-06	8.89e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ACHE—breast cancer	6.62e-06	8.89e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NAT2—breast cancer	6.58e-06	8.85e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP17A1—breast cancer	6.26e-06	8.42e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS1—breast cancer	6.2e-06	8.33e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ENO1—breast cancer	6.2e-06	8.33e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.18e-06	8.3e-05	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKT1—breast cancer	6.11e-06	8.21e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.1e-06	8.19e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2D6—breast cancer	6.08e-06	8.17e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOA2—breast cancer	5.97e-06	8.02e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FASN—breast cancer	5.79e-06	7.78e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MED12—breast cancer	5.77e-06	7.76e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—DPYD—breast cancer	5.77e-06	7.76e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—BCHE—breast cancer	5.76e-06	7.74e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC5A5—breast cancer	5.69e-06	7.65e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDOA—breast cancer	5.68e-06	7.64e-05	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKT1—breast cancer	5.68e-06	7.63e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOA3—breast cancer	5.52e-06	7.42e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC2A1—breast cancer	5.5e-06	7.39e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NQO1—breast cancer	5.5e-06	7.39e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC2A2—breast cancer	5.48e-06	7.36e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.38e-06	7.23e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTR—breast cancer	5.37e-06	7.21e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCG2—breast cancer	5.37e-06	7.21e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CPT1A—breast cancer	5.37e-06	7.21e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP3A4—breast cancer	5.36e-06	7.2e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.33e-06	7.17e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP1B1—breast cancer	5.27e-06	7.08e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HPGDS—breast cancer	5.26e-06	7.07e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HBA1—breast cancer	5.23e-06	7.03e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HSP90AA1—breast cancer	5.17e-06	6.95e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTT1—breast cancer	5.11e-06	6.86e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ACHE—breast cancer	5.11e-06	6.86e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOA1—breast cancer	5.03e-06	6.76e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—STK11—breast cancer	4.96e-06	6.66e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP19A1—breast cancer	4.96e-06	6.66e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP17A1—breast cancer	4.83e-06	6.49e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ENO1—breast cancer	4.78e-06	6.43e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS1—breast cancer	4.78e-06	6.43e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2D6—breast cancer	4.69e-06	6.3e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.65e-06	6.25e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—COMT—breast cancer	4.61e-06	6.19e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOA2—breast cancer	4.61e-06	6.19e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTP1—breast cancer	4.59e-06	6.16e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HMOX1—breast cancer	4.52e-06	6.08e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ITPR1—breast cancer	4.51e-06	6.06e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FASN—breast cancer	4.47e-06	6e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—BCHE—breast cancer	4.45e-06	5.98e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC5A5—breast cancer	4.39e-06	5.9e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCB1—breast cancer	4.34e-06	5.83e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TYMS—breast cancer	4.26e-06	5.73e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC2A1—breast cancer	4.24e-06	5.7e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NQO1—breast cancer	4.24e-06	5.7e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOR1—breast cancer	4.21e-06	5.66e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLA2G4A—breast cancer	4.21e-06	5.66e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—breast cancer	4.21e-06	5.66e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1B1—breast cancer	4.07e-06	5.47e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPX1—breast cancer	4.04e-06	5.42e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP1A1—breast cancer	3.99e-06	5.37e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.99e-06	5.36e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ERCC2—breast cancer	3.96e-06	5.32e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOA1—breast cancer	3.88e-06	5.22e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—STK11—breast cancer	3.82e-06	5.14e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP19A1—breast cancer	3.82e-06	5.14e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTHFR—breast cancer	3.72e-06	5e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—COMT—breast cancer	3.56e-06	4.78e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTP1—breast cancer	3.54e-06	4.76e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HMOX1—breast cancer	3.49e-06	4.69e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ITPR1—breast cancer	3.48e-06	4.68e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CAV1—breast cancer	3.43e-06	4.62e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCB1—breast cancer	3.35e-06	4.5e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TYMS—breast cancer	3.29e-06	4.42e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.28e-06	4.41e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.25e-06	4.37e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOR1—breast cancer	3.25e-06	4.37e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—breast cancer	3.25e-06	4.37e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CG—breast cancer	3.13e-06	4.2e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPX1—breast cancer	3.11e-06	4.19e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1A1—breast cancer	3.08e-06	4.14e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ERCC2—breast cancer	3.06e-06	4.11e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTHFR—breast cancer	2.87e-06	3.86e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CD—breast cancer	2.75e-06	3.7e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—breast cancer	2.72e-06	3.65e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CAV1—breast cancer	2.65e-06	3.56e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NOS3—breast cancer	2.6e-06	3.49e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CG—breast cancer	2.41e-06	3.25e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CB—breast cancer	2.4e-06	3.22e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—breast cancer	2.38e-06	3.19e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CD—breast cancer	2.12e-06	2.85e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—breast cancer	2.1e-06	2.82e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTEN—breast cancer	2.07e-06	2.78e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NOS3—breast cancer	2e-06	2.69e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.85e-06	2.49e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—breast cancer	1.83e-06	2.46e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTEN—breast cancer	1.6e-06	2.15e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CA—breast cancer	1.46e-06	1.96e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKT1—breast cancer	1.19e-06	1.6e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CA—breast cancer	1.13e-06	1.52e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKT1—breast cancer	9.21e-07	1.24e-05	CbGpPWpGaD
